{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:18:27Z","timestamp":1790806707414,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":140,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.tmrv.2024.150835","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T14:17:37Z","timestamp":1721830657000},"page":"150835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6683-5348","authenticated-orcid":false,"given":"Marc","family":"Bienz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Ru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2024.150835_sbref0001","series-title":"Hepatitis E CDC Yellow Book 2024: Centers for Disease Control and Prevention (CDC)","first-page":"1","author":"Teshale","year":"2024"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000499121","article-title":"Blood donor screening for hepatitis E virus in the European Union","volume":"46","author":"Boland","year":"2019","journal-title":"Transfus Med Hemother"},{"issue":"10","key":"10.1016\/j.tmrv.2024.150835_bib0003","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/jvh.13161","article-title":"Hepatitis E virus prevalence in Flemish blood donors","volume":"26","author":"Vercouter","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.tmrv.2024.150835_bib0004","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1751-2824.2011.01512.x","article-title":"Hepatitis E virus infection and blood transfusion in Japan","volume":"6","author":"Matsubayashi","year":"2011","journal-title":"ISBT Sci Ser"},{"issue":"4","key":"10.1016\/j.tmrv.2024.150835_bib0005","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28436","article-title":"A nationwide survey of hepatitis E viral infection in French blood donors","volume":"63","author":"Mansuy","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0006","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/trf.13402","article-title":"Incidence and duration of hepatitis E virus infection in Dutch blood donors","volume":"56","author":"Hogema","year":"2016","journal-title":"Transfusion (Paris)"},{"issue":"10","key":"10.1016\/j.tmrv.2024.150835_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/1560-7917.ES.2019.24.10.1800386","article-title":"Hepatitis E virus in blood donors in England, 2016 to 2017: from selective to universal screening","volume":"24","author":"Harvala","year":"2019","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.tmrv.2024.150835_bib0008","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/vox.12056","article-title":"Hepatitis E virus in Scottish blood donors","volume":"105","author":"Cleland","year":"2013","journal-title":"Vox Sang"},{"issue":"6","key":"10.1016\/j.tmrv.2024.150835_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198045","article-title":"Hepatitis E virus genotypes and subgenotypes causing acute hepatitis, Bulgaria, 2013-2015","volume":"13","author":"Bruni","year":"2018","journal-title":"PLoS One"},{"issue":"31","key":"10.1016\/j.tmrv.2024.150835_bib0010","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES2013.18.31.20550","article-title":"Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012","volume":"18","author":"Slot","year":"2013","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0011","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.tmrv.2019.06.001","article-title":"Transfusion-transmitted hepatitis E virus infection in France","volume":"33","author":"Gallian","year":"2019","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2024.150835_bib0012","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/vir.0.068429-0","article-title":"Consensus proposals for classification of the family Hepeviridae","volume":"95","author":"Smith","year":"2014","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.tmrv.2024.150835_bib0013","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s10096-019-03534-x","article-title":"Pathogenic mechanisms and current epidemiological status of HEV infection in asymptomatic blood donors and patients with chronic diseases","volume":"38","author":"Albano","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/JCM.40.1.117-122.2002","article-title":"Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and Other Countries","volume":"40","author":"Meng","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/tme.12405","article-title":"Hepatitis E: the current state of play","volume":"27","author":"Ankcorn","year":"2017","journal-title":"Transfus Med"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3748\/wjg.v28.i1.47","article-title":"Transfusion-transmitted hepatitis E: what we know so far?","volume":"28","author":"Cheung","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0017","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/trf.13994","article-title":"Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression","volume":"57","author":"Satake","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/v13020267","article-title":"Advances in hepatitis E virus biology and pathogenesis","volume":"13","author":"Lin","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.tmrv.2024.150835_bib0019","first-page":"e04886","article-title":"Public health risks associated with hepatitis E virus (HEV) as a food-borne pathogen","volume":"15","author":"Ricci","year":"2017","journal-title":"EFSA J."},{"key":"10.1016\/j.tmrv.2024.150835_bib0020","doi-asserted-by":"crossref","unstructured":"Walachowski S, Dorenlor V, Lefevre J, Lunazzi A, Eono F, Merbah T, et al. Risk factors associated with the presence of hepatitis E virus in livers and seroprevalence in slaughter-age pigs: a retrospective study of 90 swine farms in France. Epidemiol Infect. 142(9): 1934\u20131944.","DOI":"10.1017\/S0950268813003063"},{"issue":"190","key":"10.1016\/j.tmrv.2024.150835_bib0021","first-page":"1","article-title":"Prevalence and transmission of hepatitis E virus in domestic swine populations in different European countries","volume":"5","author":"Berto","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.tmrv.2024.150835_bib0022","article-title":"Canada: number of farms classified under \u201cHog and pig farming\u201d in the North American Industry Classification System by census division (CD), 2016","year":"2017","journal-title":"In: Agriculture Division CoA, editor. Statistics Canada\/Statistique Canada"},{"issue":"6","key":"10.1016\/j.tmrv.2024.150835_bib0023","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1128\/CDLI.8.6.1213-1219.2001","article-title":"Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus","volume":"8","author":"Yoo","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.tmrv.2024.150835_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.onehlt.2023.100570","article-title":"Farm biosecurity measures to prevent hepatitis E virus infection in finishing pigs on endemically infected pig farms","volume":"16","author":"Meester","year":"2023","journal-title":"One Health"},{"issue":"10","key":"10.1016\/j.tmrv.2024.150835_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/v11100883","article-title":"Hepatitis E Virus Entry","volume":"11","author":"Yin","year":"2019","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0026","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1017\/S0950268813003063","article-title":"Risk factors associated with the presence of hepatitis E virus in livers and seroprevalence in slaughter-age pigs: a retrospective study of 90 swine farms in France","volume":"142","author":"Walachowski","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.tmrv.2024.150835_bib0027","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.4315\/0362-028X-70.12.2889","article-title":"Hepatitis E virus RNA in commercial porcine livers in The Netherlands","volume":"70","author":"Bouwknegt","year":"2007","journal-title":"J Food Prot"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0028","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00430-011-0221-2","article-title":"Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs","volume":"201","author":"Dremsek","year":"2012","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.tmrv.2024.150835_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fsufs.2023.1163507","article-title":"High occurrence of hepatitis E virus in raw pork liver and pork liver p\u00e2t\u00e9 produced in the Canadian province of Quebec","volume":"7","author":"Chatonnat","year":"2023","journal-title":"Front Sustain Food Syst"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12560-017-9281-9","article-title":"Prevalence and molecular characterization of the hepatitis E virus in retail pork products marketed in Canada","volume":"9","author":"Mykytczuk","year":"2017","journal-title":"Food Environ Virol"},{"key":"10.1016\/j.tmrv.2024.150835_bib0031","first-page":"27","article-title":"Molecular characterization of Hepatitis E virus detected in swine farms in the province of Quebec","volume":"72","author":"Ward","year":"2008","journal-title":"CJVR"},{"issue":"15","key":"10.1016\/j.tmrv.2024.150835_bib0033","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1128\/AEM.00436-12","article-title":"Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food","volume":"78","author":"Barnaud","year":"2012","journal-title":"Appl Environ Microb"},{"issue":"6","key":"10.1016\/j.tmrv.2024.150835_bib0032","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3201\/eid2706.203964","article-title":"Case-Control study of risk factors for acquired hepatitis E Virus infections in blood donors, United Kingdom, 2018-2019","volume":"27","author":"Smith","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2024.150835_bib0034","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/tbed.12582","article-title":"Risk profile of hepatitis E virus from pigs or pork in Canada","volume":"64","author":"Wilhelm","year":"2016","journal-title":"Transbound Emerg Dis"},{"issue":"23","key":"10.1016\/j.tmrv.2024.150835_bib0035","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/rmv.1929","article-title":"Hepatitis E and pregnancy: current state","volume":"27","author":"P\u00e9rez-Garcia","year":"2017","journal-title":"Rev Med Virol"},{"issue":"9835","key":"10.1016\/j.tmrv.2024.150835_bib0037","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet."},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0038","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jceh.2013.08.013","article-title":"Hepatitis E and acute-on-chronic liver failure","volume":"3","author":"Kumar","year":"2013","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneurol.2015.234","article-title":"Hepatitis E virus and neurological injury","volume":"12","author":"Dalton","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.tmrv.2024.150835_bib0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000000112","article-title":"Neuralgic amyotrophy and hepatitis E virus infection","volume":"82","author":"van Eijk","year":"2014","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.tmrv.2024.150835_bib0041","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/pathogens10121582","article-title":"Hepatitis E virus infection: neurological manifestations and pathophysiology","volume":"10","author":"Lhomme","year":"2021","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0042","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3201\/eid2809.220487","article-title":"Fulminant transfusion-associated hepatitis E virus infection despite screening, England, 2016-2020","volume":"28","author":"Harvala","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmrv.2024.150835_bib0043","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.tmrv.2024.150835_bib0044","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E Virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2019.04.022","article-title":"The burden of hepatitis E among patients with haematological malignancies: a retrospective European cohort study","volume":"71","author":"von Felden","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.tmrv.2024.150835_bib0046","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","author":"EAftSot","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0047","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/jvh.13456","article-title":"Treatment for chronic hepatitis E virus infection: A systematic review and meta-analysis","volume":"28","author":"Gorris","year":"2021","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0048","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12879-019-4190-1","article-title":"Why all blood donations should be tested for hepatitis E virus (HEV)","volume":"19","author":"Denner","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0049","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/trf.17498","article-title":"Transfusion-transmission of hepatitis E virus through red blood cell transfusion but not through platelet concentrates: a case report from Spain","volume":"6","author":"Ojea","year":"2023","journal-title":"Transfusion (Paris)"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pathogens12030425","article-title":"Higher risk of HEV transmission and exposure among blood donors in Europe and Asia in comparison to North America: a meta-analysis","volume":"12","author":"Wolski","year":"2023","journal-title":"Pathogens"},{"issue":"35","key":"10.1016\/j.tmrv.2024.150835_bib0088","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES.2016.21.35.30332","article-title":"Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011","volume":"21","author":"Vollmer","year":"2016","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0066","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1423-0410.2011.01583.x","article-title":"Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States","volume":"103","author":"Baylis","year":"2012","journal-title":"Vox Sang"},{"issue":"9956","key":"10.1016\/j.tmrv.2024.150835_bib0053","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.tmrv.2024.150835_bib0089","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3201\/eid2011.140516","article-title":"Hepatitis E virus infections in blood donors","volume":"20","author":"Gallian","year":"2014","journal-title":"France. Emerg Infect Dis."},{"issue":"7","key":"10.1016\/j.tmrv.2024.150835_bib0090","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/vox.12559","article-title":"Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment","volume":"112","author":"Hoad","year":"2017","journal-title":"Vox Sang"},{"issue":"22","key":"10.1016\/j.tmrv.2024.150835_bib0091","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES.2022.27.22.2100516","article-title":"Prevalence and risk factors for hepatitis E virus infection in blood donors: a nationwide survey in Italy, 2017 to 2019","volume":"27","author":"Spada","year":"2022","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0092","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3201\/eid2801.211466","article-title":"Effect of hepatitis E virus RNA universal blood donor screening, Catalonia, Spain, 2017\u20122020","volume":"28","author":"Bes","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0093","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/jvh.13682","article-title":"Evaluating the prevalence of Hepatitis E virus infection in a large cohort of European blood donors, 2015-2018","volume":"29","author":"Healy","year":"2022","journal-title":"J Viral Hepat"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0094","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/pathogens12030484","article-title":"Hepatitis E Virus in Finland: epidemiology and Risk in Blood Donors and in the General Population","volume":"12","author":"M\u00e4tt\u00f6","year":"2023","journal-title":"Pathogens"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0051","first-page":"110","article-title":"Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives","volume":"21","author":"Laperche","year":"2023","journal-title":"Blood Transfus"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/trf.17696","article-title":"Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion-transmitted infection in Japan","volume":"64","author":"Tanaka","year":"2024","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0052","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2018.02.031","article-title":"HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients","volume":"69","author":"Westholter","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0054","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/vox.12887","article-title":"Prevalence of hepatitis E viraemia among blood donors: a systematic review","volume":"115","author":"Goel","year":"2020","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2024.150835_bib0055","series-title":"Guidelines from the expert advisory committee on the Safety of Blood, Tissues and Organs (SaBTO) on measures to protect patients from acquiring hepatitis E virus via transfusion or transplantation","first-page":"4","year":"2016"},{"issue":"16","key":"10.1016\/j.tmrv.2024.150835_bib0056","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/1560-7917.ES.2017.22.16.30514","article-title":"Hepatitis E and blood donation safety in selected European countries: a shift to screening?","volume":"22","author":"Domanovic","year":"2017","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.tmrv.2024.150835_bib0057","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/vox.12719","article-title":"Impact of hepatitis E virus testing on the safety of blood components in Germany - results of a simulation study","volume":"113","author":"Kamp","year":"2018","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2024.150835_bib0058","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1017\/S0950268820001429","article-title":"Hepatitis E virus and blood transfusion safety","volume":"148","author":"Bi","year":"2020","journal-title":"Epidem Inf"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0059","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0060","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/infdis\/jiu466","article-title":"Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010","volume":"211","author":"Teshale","year":"2015","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.tmrv.2024.150835_bib0061","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/jcm.35.5.1244-1247.1997","article-title":"Seroreactivity to hepatitis E virus in areas where the disease is not endemic","volume":"35","author":"Thomas","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1386-6532(99)00037-2","article-title":"Hepatitis E virus infection prevalence among selected populations in Iowa","volume":"14","author":"Karetnyi","year":"1999","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.tmrv.2024.150835_bib0063","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/trf.14089","article-title":"Hepatitis E in Canadian blood donors","volume":"57","author":"Fearon","year":"2017","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0096","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1086\/514037","article-title":"Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California","volume":"176","author":"Mast","year":"1997","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.tmrv.2024.150835_bib0097","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1128\/JCM.05481-11","article-title":"Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States","volume":"49","author":"Dong","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmrv.2024.150835_bib0098","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1111\/trf.12326","article-title":"An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients","volume":"53","author":"Xu","year":"2013","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0064","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/trf.13355","article-title":"Hepatitis E virus: seroprevalence and frequency of viral RNA detection among US blood donors","volume":"56","author":"Stramer","year":"2016","journal-title":"Transfusion (Paris)"},{"issue":"12","key":"10.1016\/j.tmrv.2024.150835_bib0067","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/trf.14285","article-title":"Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors","volume":"57","author":"Roth","year":"2017","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2024.150835_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmrv.2019.05.017","article-title":"Hepatitis E virus infection in blood donors and risk to patients in the United States and Canada","author":"Delage","year":"2019","journal-title":"Transfus Med Rev"},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0065","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/trf.13700","article-title":"Low transfusion transmission of hepatitis E among 25,637 single-donation, nucleic acid-tested blood donors","volume":"56","author":"Harritsh\u00f8j","year":"2016","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2024.150835_bib0069","series-title":"Blood Alternatives and Transfusion Reactions","first-page":"40","article-title":"A guide to transfusion medicine, fifth edition handbook: ontario regional blood coordinating network","year":"2022"},{"issue":"10","key":"10.1016\/j.tmrv.2024.150835_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12103467","article-title":"Transfusion burden in allogeneic hematopoietic stem cell transplantation over time: experience from a single institution","volume":"12","author":"Solves","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.tmrv.2024.150835_bib0071","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/trf.15961","article-title":"Red blood cell and platelet transfusion support in the first 30 and 100\u2009days after allogeneic hematopoietic cell transplant","volume":"60","author":"Yuan","year":"2020","journal-title":"Transfusion (Paris)"},{"issue":"11","key":"10.1016\/j.tmrv.2024.150835_bib0072","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/trf.17518","article-title":"Clinical performance of a new multiplex assay for the detection of HIV-1, HIV-2, HCV, HBV, and HEV in blood donations in Catalonia (Spain)","volume":"63","author":"Sauleda","year":"2023","journal-title":"Transfusion (Paris)"},{"issue":"2","key":"10.1016\/j.tmrv.2024.150835_bib0073","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/trf.13976","article-title":"Hepatitis E risks: pigs or blood-that is the question","volume":"57","author":"Tedder","year":"2017","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.tmrv.2024.150835_bib0074","unstructured":"Infectious Disease Tests fda.gov: FDA; [updated 2020-02-13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/infectious-disease-tests."},{"key":"10.1016\/j.tmrv.2024.150835_bib0075","series-title":"Canada MoPWaGS","year":"2014"},{"key":"10.1016\/j.tmrv.2024.150835_bib0077","unstructured":"H\u00e9ma-Qu\u00e9bec. Tests conducted. Available from: https:\/\/www.hema-quebec.qc.ca\/sang\/donneur-sang\/a-quoi-dois-je-mattendre\/tests-effectues.en.html."},{"issue":"4","key":"10.1016\/j.tmrv.2024.150835_bib0078","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12560-016-9252-6","article-title":"Detection and phylogenetic analysis of the hepatitis E virus in a Canadian Swine Production Network","volume":"8","author":"Nantel-Fortier","year":"2016","journal-title":"Food Environ Virol"},{"key":"10.1016\/j.tmrv.2024.150835_bib0079","first-page":"3","article-title":"Circular information for the use of labile blood products","year":"2023","journal-title":"Hema-Quebec;"},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0080","article-title":"Recent and past HEV infection among voluntary blood donors in China: a systematic review and meta-analysis","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.tmrv.2024.150835_bib0081","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jpeds.2012.01.028","article-title":"Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant","volume":"160","author":"Halac","year":"2012","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.tmrv.2024.150835_bib0082","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gutjnl-2011-300708","article-title":"Chronic hepatitis E infection in children with liver transplantation","volume":"61","author":"Halac","year":"2012","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.tmrv.2024.150835_bib0083","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/trf.15140","article-title":"Probable transmission of hepatitis E virus (HEV) via transfusion in the United States","volume":"59","author":"Ticehurst","year":"2019","journal-title":"Transfusion (Paris)"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0084","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1097\/TXD.0000000000000852","article-title":"Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission","volume":"5","author":"White","year":"2018","journal-title":"Transplant Direct"},{"issue":"12","key":"10.1016\/j.tmrv.2024.150835_bib0085","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.3748\/wjg.v27.i12.1240","article-title":"Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis","volume":"27","author":"Hansrivijit","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.tmrv.2024.150835_bib0086","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/TP.0000000000001908","article-title":"Summary of the British Transplantation Society UK guidelines for hepatitis E and solid organ transplantation","volume":"102","author":"McPherson","year":"2018","journal-title":"Transplantation."},{"issue":"9","key":"10.1016\/j.tmrv.2024.150835_bib0087","doi-asserted-by":"crossref","first-page":"e13514","DOI":"10.1111\/ctr.13514","article-title":"Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice","volume":"33","author":"Te","year":"2019","journal-title":"Clin Transplant"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796324000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796324000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T11:32:07Z","timestamp":1733484727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796324000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0887796324000257"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2024.150835","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2024.150835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150835"}}